Tumgik
#Ophthalmic Equipment Market Share
Text
Ophthalmology Drugs and Devices Market: In-Depth Analysis & Forecast to 2032
Introduction
The ophthalmology drugs and devices market is witnessing rapid growth as the prevalence of eye disorders rises worldwide, particularly due to aging populations and the increasing prevalence of diabetes. Ophthalmic drugs and devices are essential for diagnosing, treating, and managing a range of eye-related conditions, from cataracts and glaucoma to diabetic retinopathy and macular degeneration. This article delves into the current trends, growth drivers, challenges, and future opportunities in the ophthalmology drugs and devices market, with a forecast extending to 2032.
Opthalmology Drugs Devices Market Size was estimated at 50.22 (USD Billion) in 2023. The Opthalmology Drugs Devices Market Industry is expected to grow from 53.43(USD Billion) in 2024 to 87.7 (USD Billion) by 2032. The Opthalmology Drugs Devices Market CAGR (growth rate) is expected to be around 6.39% during the forecast period (2025 - 2032).
Key Market Drivers
Several factors are driving the expansion of the ophthalmology drugs and devices market:
Rising Prevalence of Eye Disorders: The global rise in eye disorders is one of the key drivers of the market. According to the World Health Organization (WHO), over 2.2 billion people worldwide suffer from some form of visual impairment, with conditions such as cataracts, glaucoma, diabetic retinopathy, and age-related macular degeneration (AMD) being the most common. As the global population ages and diabetes becomes more prevalent, these conditions are expected to increase, creating higher demand for ophthalmic drugs and devices.
Technological Advancements in Ophthalmology Devices: Innovation in ophthalmic devices is a significant contributor to market growth. The development of advanced diagnostic tools, such as optical coherence tomography (OCT), femtosecond lasers, and intraocular lenses, has transformed eye care by enabling more precise diagnosis and minimally invasive surgical procedures. These technological advancements improve patient outcomes, reduce recovery times, and drive the adoption of such devices in hospitals and specialized eye care centers.
Growing Demand for Minimally Invasive Procedures: Patients and healthcare providers are increasingly favoring minimally invasive procedures, particularly in ophthalmic surgeries. Advanced devices such as laser-assisted cataract surgery systems and micro-invasive glaucoma surgeries (MIGS) are becoming more common, offering safer, quicker, and more effective treatments. This shift towards less invasive procedures is expected to drive the growth of the ophthalmic devices market.
Awareness and Screening Programs: As awareness of preventable blindness and eye care increases, government and healthcare organizations are implementing screening programs for early diagnosis and treatment of eye diseases. These programs are especially prominent in developed countries, but emerging markets are also investing in such initiatives. The increasing number of eye care centers and hospitals in both developed and developing regions is further accelerating the growth of the ophthalmology market.
Market Segmentation
The ophthalmology drugs and devices market can be segmented based on product type, disease type, and region.
By Product Type: The market is divided into two primary categories: ophthalmology drugs and ophthalmology devices. The drug segment includes anti-infectives, anti-inflammatories, anti-glaucoma drugs, and retinal disease therapies. Meanwhile, the device segment consists of diagnostic and monitoring equipment, surgical devices, and vision correction devices.
By Disease Type: The market addresses a wide range of eye disorders, including cataracts, glaucoma, diabetic retinopathy, macular degeneration, refractive errors, and ocular infections. Among these, cataracts and glaucoma treatments hold a significant market share, driven by their high prevalence among aging populations.
By Region: Regionally, the ophthalmology drugs and devices market is segmented into North America, Europe, Asia-Pacific, and the rest of the world. North America holds the largest share of the market, primarily due to the advanced healthcare infrastructure, high healthcare expenditure, and increasing prevalence of eye disorders in the region. Europe follows closely, with a growing elderly population and strong presence of ophthalmic device manufacturers. The Asia-Pacific region is expected to witness the fastest growth, driven by rising healthcare investments, increasing awareness of eye health, and a large patient pool.
Challenges Facing the Market
Despite the significant growth potential, the ophthalmology drugs and devices market faces some challenges:
High Cost of Advanced Devices: While technological advancements have improved the effectiveness of ophthalmic treatments, they have also driven up costs. Advanced devices, such as femtosecond lasers for cataract surgery, come with a high price tag, limiting their adoption in low- and middle-income countries. The affordability of these devices remains a challenge, especially in regions with underdeveloped healthcare systems.
Lack of Access to Eye Care in Developing Regions: In many parts of the world, particularly in low-income regions, access to basic eye care remains limited. A lack of infrastructure, trained professionals, and resources hampers the early detection and treatment of eye disorders. Addressing these disparities in healthcare access will be crucial for expanding the global market.
Regulatory Hurdles: The ophthalmology drugs and devices market is heavily regulated, particularly in the U.S. and Europe, where stringent approval processes can slow down the launch of new products. Compliance with these regulations can be time-consuming and costly for manufacturers, creating barriers to market entry for smaller companies.
Future Opportunities and Market Outlook
The future of the ophthalmology drugs and devices market looks promising, with several opportunities for growth:
Emerging Markets: The Asia-Pacific region, in particular, is expected to witness rapid market expansion due to its large patient population, rising healthcare expenditure, and growing awareness of eye health. Companies are increasingly focusing on these emerging markets to expand their customer base and tap into new growth opportunities.
Innovative Drug Therapies: The development of novel drug therapies, particularly for retinal diseases and glaucoma, will further boost the market. Biologics and gene therapies are being explored as potential treatments for various eye conditions, offering new avenues for market growth.
Telemedicine in Ophthalmology: The integration of telemedicine in ophthalmic care has gained momentum, particularly in the wake of the COVID-19 pandemic. Remote diagnostic tools and teleconsultations can help bridge the gap in access to care, especially in underserved regions, further driving the adoption of ophthalmic devices.
Conclusion
The ophthalmology drugs and devices market is poised for significant growth through 2032, driven by rising demand for advanced diagnostic tools and treatments for eye disorders. While challenges such as high costs and limited access remain, innovations in technology and increasing awareness of eye health will continue to fuel market expansion. As companies focus on emerging markets and novel therapies, the ophthalmology industry will see transformative growth over the next decade.
0 notes
colinwilson11 · 5 days
Text
The Global Ophthalmoplegia Market Will Gain Traction Owing To Increasing Diagnosis Rate
Tumblr media
The global ophthalmoplegia market comprises medicines and equipment used for treatment and diagnosis of eye muscle paralysis or limited eye movement, known as ophthalmoplegia. Some key products include diagnostic equipment such as funduscopy, echography and electroretinography machinery used for retina examination. Treatment includes drug therapies such as acetylcholinesterase inhibitors, prostaglandin analogues and alpha agonists. Ophthalmoplegia negatively impacts vision by restricting eye movement and convergence of eyes. It arises due to neuropathies or neuromuscular junction disorders. With growing geriatric population more prone to neurodegenerative diseases and rising healthcare expenditures, diagnosis and treatment seeking rate for ophthalmoplegia is increasing.
The Global Ophthalmoplegia Market is estimated to be valued at US$ 510 Mn in 2024 and is expected to exhibit a CAGR of 7.5% over the forecast period 2024-2031.
Key Takeaways
Key players operating in the global ophthalmoplegia market are Novartis AG, Sanofi, F. Hoffmann-La Roche Ltd., Pfizer Inc., Bayer AG. These players are engage in new product launches and geographic expansion to gain market share. For instance, in 2023 Novartis launched Rixadyl, a treatment for myasthenia gravis which can potentially treat ophthalmoplegia arising from the condition.
The increasing prevalence of neurological disorders is a major factor driving the demand for ophthalmoplegia treatment. Neuropathies related to diabetes and neurodegenerative diseases like myasthenia gravis and Graves' disease are key causative factors. According to WHO, over 422 million people worldwide have diabetes in 2014, anticipated to rise to over 592 million by 2035. This rises risk of diabetic neuropathies and associated ophthalmoplegia.
Technological advancements are helping improve disease diagnosis. Optical coherence tomography enables high resolution retina imaging without contact. Advances in electrodiagnostic testing aid in accurate neuromuscular junction and neuropathy assessment. Wearable eye trackers also aid in home based monitoring of ophthalmic symptoms, facilitate remote diagnosis.
Market Trends
Increased drug pipeline for orphan ophthalmoplegia indications - Several pharmaceutical companies are developing therapies for rare causes of ophthalmoplegia like Miller Fisher Syndrome. For instance, Alexion Pharma is developing a C5 complement inhibitor ALXN1720 for this syndrome.
Growing diagnostic device industry - Major players are launching portable and affordable devices using technologies like optical coherence tomography, electroretinography for remote patient monitoring and decentralized healthcare access.
Market Opportunities
Emerging markets in Asia Pacific and Latin America present high growth potential for ophthalmoplegia drug makers and device companies. Growing medical tourism and healthcare infrastructure development in these regions can be leveraged.
Shift towards home-based remote care models post Covid - Telehealth platforms enabling virtual consultations and remote monitoring present an opportunity for players to deliver decentralized care using diagnostic devices, virtual training programs for patients.
Impact Of COVID-19 On Global Ophthalmoplegia Market Growth:
The COVID-19 pandemic has significantly impacted the growth of the global ophthalmoplegia market. During the initial phase of the pandemic, lockdowns and social distancing measures implemented worldwide disrupted the supply chains and stalled production activities. This adversely affected the market's growth in the short term. With reduced access to healthcare facilities, diagnosis and treatment of ophthalmoplegia also witnessed delays.
However, with increasing availability of teleconsultation and telemedicine options post lockdowns, the ability to diagnose and manage cases remotely helped the market regain traction. Additionally, rising awareness about the risk of viral infections aggravated by ophthalmoplegia motivated people to seek timely medical care. Government efforts to prioritize availability of essential drugs and treatments for chronic conditions also supported market recovery.
While short-term prospects were impacted, the long-term outlook for the market remains positive. The pandemic highlighted the importance of eye care and ophthalmoplegia management. It is expected that higher focus on preventive healthcare would drive increased adoption of diagnostic tests and treatment regimens. Drug makers are also exploring development of more effective and affordable treatment options to cater to the growing needs of such patients. Overall, with resumption of normal activities and continued medical advancements, the market is projected to regain growth momentum in the coming years.
Geographical Regions With Highest Value Concentration In Global Ophthalmoplegia Market:
North America represents the largest regional market for ophthalmoplegia, in terms of value. Advanced healthcare infrastructure and widespread medical insurance have enabled high adoption of diagnostic procedures and specialty drug therapies in the region. With presence of prominent market players and continuous investments in R&D, the US market within North America dominates global sales. In Europe, government-funded healthcare systems ensure accessibility of treatment options. Germany, France and the UK contribute major shares to the European market. Rising incomes and growing medical tourism are factors fueling the Asia Pacific market growth. China and India have emerged as high potential markets based on their large patient pools. Other regions including Latin America and Middle East & Africa are also witnessing steady expansion of the ophthalmoplegia market.
Fastest Growing Regional Market For Global Ophthalmoplegia:
The Asia Pacific region is poised to register the fastest market growth during the forecast period. This can be attributed to rising incidences of myasthenia gravis and Graves' disease, both of which increase risks of ophthalmoplegia. Improving healthcare infrastructure and expanding insurance coverage have enhanced diagnosis rates across major Asian countries. Additionally, increasing collaboration between international and local pharma companies is facilitating technology transfer and availability of novel drug formulations. Governments are also implementing various initiatives to spread awareness about neurological and ophthalmic conditions. These favorable market determinants are supporting strong sales growth prospects for ophthalmoplegia treatment in Asia Pacific. Other emerging regions including Latin America and Middle East Africa are also projected to provide lucrative opportunities for market expansion in the long run.
Get more insights on this topic: https://www.trendingwebwire.com/global-ophthalmoplegia-market-to-grow-due-to-advancements-in-neurological-disorder-treatments/
About Author:
Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. (https://www.linkedin.com/in/ravina-pandya-1a3984191)
What Are The Key Data Covered In This Global Ophthalmoplegia Market Report?
:- Market CAGR throughout the predicted period
:- Comprehensive information on the aspects that will drive the Global Ophthalmoplegia Market's growth between 2024 and 2031.
:- Accurate calculation of the size of the Global Ophthalmoplegia Market and its contribution to the market, with emphasis on the parent market
:- Realistic forecasts of future trends and changes in consumer behaviour
:- Global Ophthalmoplegia Market Industry Growth in North America, APAC, Europe, South America, the Middle East, and Africa
:- A complete examination of the market's competitive landscape, as well as extensive information on vendors
:- Detailed examination of the factors that will impede the expansion of Global Ophthalmoplegia Market vendors
FAQ’s
Q.1 What are the main factors influencing the Global Ophthalmoplegia Market?
Q.2 Which companies are the major sources in this industry?
Q.3 What are the market’s opportunities, risks, and general structure?
Q.4 Which of the top Global Ophthalmoplegia Market companies compare in terms of sales, revenue, and prices?
Q.5 Which businesses serve as the Global Ophthalmoplegia Market’s distributors, traders, and dealers?
Q.6 How are market types and applications and deals, revenue, and value explored?
Q.7 What does a business area’s assessment of agreements, income, and value implicate?
*Note: 1. Source: Coherent Market Insights, Public sources, Desk research 2. We have leveraged AI tools to mine information and compile it
0 notes
kathansky · 10 days
Text
Medical Products Market Size, Share, Growth Analysis | 2024-2031
Leading market research firm SkyQuest Technology Group recently released a study titled 'Medical Products Market Global Size, Share, Growth, Industry Trends, Opportunity and Forecast 2024-2031,' This study Medical Products report offers a thorough analysis of the market, as well as competitor and geographical analysis and a focus on the most recent technological developments. The research study on the Medical Products Market extensively demonstrates existing and upcoming opportunities, profitability, revenue growth rates, pricing, and scenarios for recent industry analysis. The research analysis on the global Medical Products Market report 2024 offers a close watch on top industry rivals along with briefings on their company profiles, strategical surveys, micro as well as macro industry trends, futuristic scenarios, analysis of pricing structure, and an all-encompassing overview of the Medical Products Market circumstances in the forecast period between 2024 and 2031. The global Medical Products Market is a dynamic and rapidly evolving sector, encompassing the development, production, and distribution. This market is essential for improving global market and driving economic growth through innovation and industry advancements. Market Growth The Medical Products Market has experienced robust growth over the past decade and is projected to continue expanding. Global Medical Products Market size was valued at USD 508.20 billion in 2022 and is poised to grow from USD 542.55 billion in 2023 to USD 915.61 billion by 2031, at a CAGR of 6.76% during the forecast period (2024-2031). This growth is driven by several factors, including an aging global population, increasing prevalence of advancements in technology, and rising global expenditure.
Chance to get a free sample @ https://www.skyquestt.com/sample-request/medical-products-market 
Detailed Segmentation and Classification of the report (Market Size and Forecast - 2031, Y-o-Y growth rate, and CAGR): The Medical Products Market can be segmented based on several factors, including product type, application, end-user, and distribution channel. Understanding these segments is crucial for companies looking to target specific markets and tailor their offerings to meet consumer needs.
Product Type
Wheelchairs {Manual Wheelchair [Folding Frame Manual Wheelchairs, Rigid Frame Manual Wheelchairs], Powered Wheelchair}, Medical Beds {Patient Beds, Examination Beds, Massage Beds, Gurneys Beds}, Walkers {Double Handed Walkers, Single Handed Walkers}, Bathroom Assistive Products {Commodes, Bathtub Seats, Shower Seats}, Orthopedics {Cervical Collar Support, Shoulder Support, Arm Sling, Wrist Splint, Abdominal Binder, Maternity Belt, Elastic Bandage, Air Shield Walker, Knee Support
Device Type
In-Vitro Diagnostics, Dental Equipment, Ophthalmic Devices, Diagnostic Equipment, Hospital Supplies, Cardiovascular Devices, Surgical Equipment, Patient Monitoring Devices, Orthopedic Devices, Diabetes Care Devices, Nephrology, Urology Devices, ENT Devices, Anesthesia, Respiratory Devices, Neurology Devices, Wound Care Devices
End-Use
Hospitals, Ambulatory Surgical Centers, Home Healthcare
Application
Urology, Cardiology, Radiology, IVD
Distribution Channel
Online, Offline
Get your customized report @ https://www.skyquestt.com/speak-with-analyst/medical-products-market 
Following are the players analyzed in the report:
Medtronic (Ireland)
Stryker (US)
Johnson & Johnson Services, Inc. (US)
Fresenius SE & Co. KGaA (Germany)
Koninklijke Philips N.V. (Netherlands)
F. Hoffmann-La Roche Ltd (Switzerland)
General Electric Company (US)
Siemens Healthineers AG (Germany)
BD (US)
Boston Scientific Corporation (US)
Regional Analysis 1. North America: - The United States and Canada dominate the North American Medical Products Market. The U.S. is the largest market globally, driven by advanced global infrastructure, high R&D investments, and significant Medical Products consumption. 2. Europe: - Europe is a significant player, with major Medical Products Markets in Germany, France, and the United Kingdom. The region benefits from strong regulatory frameworks, high industry standards, and a robust R&D sector. 3. Asia-Pacific: - This region is experiencing rapid growth, with countries like China and India leading the charge. Factors such as increasing industry access, growing middle-class populations, and expanding Medical Products manufacturing capabilities contribute to this growth. 4. Latin America: - Brazil and Mexico are key markets in Latin America. Growth in this region is driven by rising industry needs, increasing investments in industry infrastructure, and a growing demand for affordable medications. 5. Middle East and Africa: - The Medical Products Market in this region is expanding due to rising market spending, increased prevalence of diseases, and improvements in Market infrastructure, although the market is relatively smaller compared to other regions. Future Outlook The Medical Products Market is poised for continued growth driven by technological advancements, expanding global market access, and increasing global industry needs. As the industry adapts to evolving challenges and seizes emerging opportunities, it is likely to see ongoing innovation and expansion, contributing significantly to global health and economic development.
Buy your full report: https://www.skyquestt.com/buy-now/medical-products-market 
0 notes
Text
The veterinary surgical instruments market is poised for steady growth, projected to reach USD 1,830.43 million by 2032, reflecting a robust compound annual growth rate (CAGR) of 5.20%.The veterinary surgical instruments market is a vital segment of the global medical devices industry, catering to the needs of animal healthcare. As veterinary medicine advances and the demand for high-quality animal care increases, the market for surgical instruments designed for veterinary procedures is expanding rapidly. This article delves into the current trends, key drivers, challenges, and future outlook of the veterinary surgical instruments market.
Browse the full report at https://www.credenceresearch.com/report/veterinary-surgical-instruments-market
Market Overview
Veterinary surgical instruments are specialized tools used by veterinarians to perform surgeries on animals. These instruments range from basic scalpels and forceps to advanced endoscopic equipment and laser devices. The market for these instruments has been growing due to several factors, including increased pet ownership, rising awareness about animal health, and advancements in veterinary surgical technologies.
Key Drivers
1. Growing Pet Ownership: The increasing number of pet owners globally is one of the primary drivers of the veterinary surgical instruments market. Pets are increasingly considered family members, and their owners are willing to invest in high-quality medical care, including surgeries. This trend has led to a higher demand for advanced surgical instruments and technologies.
2. Advancements in Veterinary Medicine: The continuous advancements in veterinary medicine and surgical techniques have led to the development of sophisticated instruments. Innovations such as minimally invasive surgery, robotics, and advanced imaging technologies are driving the demand for specialized surgical tools.
3. Rising Animal Health Awareness: There is a growing awareness about the importance of animal health and well-being. This has led to increased spending on veterinary services, including surgical procedures, and a subsequent rise in the demand for advanced surgical instruments.
4. Expansion of Veterinary Clinics: The increasing number of veterinary clinics and hospitals worldwide is contributing to the market growth. These facilities require a wide range of surgical instruments to offer comprehensive care to their patients.
Market Segmentation
The veterinary surgical instruments market can be segmented based on product type, application, end-user, and geography.
1. Product Type: This segment includes various instruments such as surgical scissors, forceps, needle holders, scalpels, and electrosurgical devices. The market is also witnessing growth in specialized instruments designed for specific types of surgeries.
2. Application: The market is divided based on applications such as orthopedic surgery, soft tissue surgery, dental surgery, and ophthalmic surgery. Each application requires specific types of instruments, influencing market dynamics.
3. End-User: Key end-users include veterinary clinics, hospitals, and research laboratories. Each of these segments has different needs and requirements, affecting the demand for specific types of surgical instruments.
4. Geography: The market is geographically segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America and Europe currently hold significant shares due to advanced healthcare infrastructure and high pet ownership rates. However, the Asia Pacific region is expected to witness the highest growth rate due to increasing veterinary care services and rising disposable incomes.
Challenges
Despite the positive outlook, the veterinary surgical instruments market faces several challenges:
1. High Costs: The cost of advanced surgical instruments can be prohibitively high, particularly for small veterinary practices. This can limit the adoption of the latest technologies and instruments.
2. Regulatory Issues: The veterinary surgical instruments market is subject to stringent regulatory requirements and standards. Compliance with these regulations can be challenging and costly for manufacturers.
3. Lack of Skilled Professionals: The effective use of advanced surgical instruments requires highly skilled veterinary professionals. A shortage of trained veterinarians can impact the demand and utilization of sophisticated instruments.
Future Outlook
The future of the veterinary surgical instruments market looks promising, with several trends likely to shape its growth:
1. Technological Advancements: Continued innovation in surgical technologies, including the development of robotic surgery systems and advanced imaging techniques, will drive market growth. These advancements will enhance the precision and effectiveness of veterinary surgeries.
2. Increasing Focus on Animal Welfare: There will be a growing emphasis on animal welfare and preventive care, leading to increased investments in veterinary surgical instruments and technologies.
3. Emerging Markets: As veterinary care continues to expand in emerging markets, there will be significant opportunities for growth. Companies that can offer cost-effective solutions and adapt to local needs will likely succeed in these regions.
 Key player:
Braun SE
Medtronic
Jorgen Kruuse A/S
Smiths Group plc
Neogen Corporation
STERIS
DRE Veterinary
Surgical Holdings
GerMedUSA
World Precision Instruments
Sklar Surgical Instruments
Integra LifeSciences
Im3 Inc.
Ethicon US LLC
Segments:
By Product
Handheld Devices
Forceps
Scalpels
Surgical Scissors
Hooks & Retractors
Others
Electrosurgery Instruments
Sutures, Staplers, And Accessories
Others
By Animal Type
Large Animal
Small Animal
By Application
Soft Tissue Surgery
Cardiovascular Surgery
Ophthalmic Surgery
Dental Surgery
Orthopedic Surgery
Others
By Regional
North America
The U.S.
Canada
Europe
The U.K.
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
Japan
China
India
Australia
Thailand
South Korea
Latin America
Brazil
Mexico
Argentina
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
Browse the full report at https://www.credenceresearch.com/report/veterinary-surgical-instruments-market
About Us:
Credence Research is committed to employee well-being and productivity. Following the COVID-19 pandemic, we have implemented a permanent work-from-home policy for all employees.
Contact:
Credence Research
Please contact us at +91 6232 49 3207
0 notes
Text
The global lateral flow assays market, valued at $10.8 billion in 2023, is expected to reach $16.8 billion by 2029, growing at a CAGR of 7.6%. This growth is driven by the rising adoption of kits & reagents and lateral flow assay readers for various applications, including infectious disease testing, veterinary diagnostics, and drug abuse testing. However, challenges such as qualitative detection limitations and variability in results may hinder market growth. The increase in eye disorders like diabetic retinopathy and cataracts is a significant driver, while the rising adoption of refurbished equipment presents a restraint. Opportunities exist in the low adoption of phacoemulsification devices and premium IOLs in emerging regions. North America holds the largest market share, with significant investments in ophthalmic technology, while the Asia Pacific is the fastest-growing region. Key players include Abbott, Roche, Danaher Corporation and Siemens Healthineers. Recent developments include new authorizations and product launches by QuidelOrtho, Abbott, and Roche.
0 notes
fadingtrashkitty · 3 months
Text
0 notes
sudheervanguri · 3 months
Text
Lupin Indore: Operator Roles Available in Derma Production and Ophthalmic Packing Lupin Limited, a renowned pharmaceutical company with a strong presence in the regulatory market, is looking for skilled professionals for Operator roles in Derma Production and Ophthalmic Packing at our Indore location. If you have the required qualifications and experience, we invite you to be part of our team and contribute to our mission of delivering high-quality healthcare solutions. Job Details: Operator – Derma Production Location: Indore, India Qualification: D. Pharm / Diploma / B.Sc. Experience: 2-7 Years Responsibilities:  Good Technical knowledge, handling of Filling machine and confident enough to run smoothly. Good knowledge on Filling machine like Sofbag Filling machine (Make: Marchesini, Tube Filling machine (Make: Norden & IMA-PG, Bottle Filling Machine (Make-PKB) and confident enough h to run smoothly. Having filling experience in Tubes, Bottles & sofbag of different formulation like Topical Solution, Ointments, Creams, Spray Lotion and Gel. Having experience of Regulatory Audits like USFDA & MHRA etc. Well versed with GMP and GDP and Good communication skill. Good knowledge on online training program like SABA. Desired Skills: Strong technical knowledge and handling of filling machines. Experience with regulatory audits and compliance. Proficiency in GMP and GDP. Good communication skills and the ability to participate in online training. Application: Interested candidates can share their resumes at [email protected] or [email protected]. Labeling Operator – Ophthalmic Packing Location: Indore, India Department: Packing Qualification: D. Pharm / Diploma / B.Sc. Experience: 3-8 Years Responsibilities: Work in the Ophthalmic Packing department with a focus on regulatory compliance. Operate and manage packing equipment efficiently. Ensure compliance with USFDA regulations and maintain high standards of packing quality. Prepare for and participate in regulatory audits. Maintain accurate documentation and follow GDP. Desired Skills: Experience in a Pharmaceutical Regulatory Plant. Familiarity with ophthalmic packing processes. Strong understanding of regulatory requirements and compliance. Excellent attention to detail and documentation skills. Application: Interested candidates can share their resumes at [email protected] or [email protected]. [caption id="attachment_58299" align="aligncenter" width="930"] Lupin Limited Recruitment Notification[/caption]
0 notes
The Eye Care Market Trends, and Key Players
The eye care market is a vital and rapidly evolving sector within the healthcare industry, offering a wide range of products and services to maintain and improve vision health. In this comprehensive blog post, we will delve into the essential insights, trends, and major players shaping the eye care market, covering market size, share, growth, prevailing trends, and the key industry players driving innovation and excellence.
Tumblr media
Eye Care Market Size, Share, and Growth
The global eye care market size was valued at USD 37.1 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 5.2% from 2022 to 2030. The market is driven by factors such as the increasing prevalence of eye disorders, the growing geriatric population, and the rising awareness of the importance of eye health. Within the eye care market, the contact lenses segment dominated in 2021, accounting for the largest revenue share of 41.2%. The increasing adoption of daily disposable contact lenses and the rising popularity of multifocal and toric lenses are contributing to the segment's growth.
Market Trends
A notable trend in the eye care market is the growing adoption of digital technologies, such as telemedicine and online eye exams. The global online vision test market is expected to grow by USD 1.04 billion from 2021 to 2026, at a CAGR of 16.8%. The increasing demand for convenience and the need for eye care services during the COVID-19 pandemic have accelerated the adoption of these technologies. Another significant trend is the rising demand for blue light-blocking glasses and lenses. The global blue light glasses market is expected to grow at a CAGR of 7.2% from 2022 to 2030. The increasing use of digital devices and the potential health risks associated with blue light exposure have fueled the demand for these specialized glasses.
Eye Care Market Players
The eye care market is dominated by several key players, each with its own unique strengths and strategies. Some of the major players in the market include:
Tumblr media
Essilor International S.A. (France): A leading manufacturer of ophthalmic lenses and a major player in the global eye care market, known for its innovative products and technologies.
Johnson & Johnson Vision Care, Inc. (United States): A subsidiary of Johnson & Johnson and a major player in the contact lens market, offering a wide range of contact lenses for various needs.
Alcon Inc. (Switzerland): A global leader in eye care, offering a wide range of products and services, including surgical equipment, pharmaceuticals, and consumer eye care products.
CooperVision, Inc. (United States): A leading manufacturer of contact lenses and a major player in the global eye care market, known for its specialty lenses for astigmatism and presbyopia.
Bausch + Lomb Corporation (United States): A global leader in eye care, offering a wide range of products and services, including contact lenses, pharmaceuticals, and consumer eye care products.
Conclusion
The eye care market is a dynamic and rapidly growing industry, driven by advancements in technology, changing consumer preferences, and increasing awareness of the importance of eye health. As the market continues to evolve, companies that prioritize innovation, convenience, and specialized solutions will lead the way in meeting the diverse needs of patients and consumers. With a focus on digital technologies, blue light protection, and personalized eye care, the eye care market is poised for continued growth and advancement in promoting vision health worldwide.
0 notes
Text
Barman Eye Care Is The Best Eye hospital in Gurgaon
Gurgaon is a busy city where rapid technological advancements are expected, and the need for quality healthcare services, especially eye care, is essential. With multiple hospitals and clinics claiming excellence, choose the right one for your vision needs. So Barman Eye Care is one of the most well-known hospitals in gurgaon, Which provides comprehensive treatments like LASIK surgery, cataract surgery, pink eye or red eye treatment, and more, with the help of a team. Dr. Keya Barman has years of experience in the eye surgery and treatment. Her purpose is to ensure that your optical vision is healthy. They give you top-notch care for your precious eyes.
Tumblr media
Situated in the heart of Gurgaon is the Galleria Market, DLF Phase IV, Sector 28, and is the premier eye care hospital in Gurgaon. With an advanced structure and a team of highly skilled ophthalmologists, Barman Eye Care offers comprehensive eye care services ranging from routine check-ups to advanced surgical procedures. Equipped with advanced technology, such as the latest laser systems and diagnostic equipment, Barman Eye Care ensures accurate diagnosis and effective treatment of various eye conditions. 
Barman Eye Care Hospital is a leading destination for eye care in Gurgaon. It boasts a dedicated ophthalmology department staffed by experienced specialists who use the latest advancements in ophthalmic care.
Barman Eye Care is a comprehensive hospital for care services, including diagnostics, medical and surgical treatment of eye diseases, and vision correction procedures. With a team of highly skilled ophthalmologists and support staff, Eye Centre prioritizes patient safety, comfort, and satisfaction, making it a significant choice for comprehensive eye care in Gurgaon. We are passionate about ethical treatment and quality care; patient satisfaction is at the heart of all our services.
Barman Eye Care is committed to innovation and research, constantly striving to improve treatment patient outcomes. The Centre for Sight, with a focus on affordability and accessibility, ensures that quality eye care is within reach for all segments of society. Dr. Keya Barman, the best eye specialist in Gurgaon and the founder and medical director, believes in teamwork and selecting people who share similar core values and have a high personal character. The proper team of skilled and compassionate people gives the patients coming to the hospital a personal touch. Patient delight is our prime concern.
Conclusion:
Choosing the right eye hospital is important for ensuring optimal vision health in a city teeming with healthcare options. The organizations above stand out as the best eye hospitals in Gurgaon, offering a combination of advanced technology, experienced specialists, and patient-centric care. 
0 notes
articleeee · 5 months
Text
Optometry Equipment Market by Size, Share, Forecasts, & Trends Analysis
Meticulous Research®—a leading global market research company, published a research report titled ‘Optometry Equipment Market by Product (OCT Scan, Perimeter, Fundus Camera, Retinoscope, Keratometer, Ophthalmic Ultrasound, Tonometer, Slit Lamp, Chart Projector), Application (Cataract, Glaucoma, AMD), End User (Clinic, Hospital) - Global Forecast to 2029.’
Download Free sample report here: https://www.meticulousresearch.com/download-sample-report/cp_id=5406?utm_source=article&utm_medium=social+&utm_campaign=product&utm_content=18-04-2024
According to this latest publication from Meticulous Research®, the global optometry equipment market is projected to reach $5.4 billion by 2029, at a CAGR of 4% during the forecast period. The increasing cases of eye diseases and disorders, rising geriatric population, excessive use of laptops & mobile phones leading to visual impairments, and rising government initiatives and funding to improve access to eye care services are the factors driving the growth of this market.
Optometry Equipment Market: Future Outlook
The global optometry equipment market is segmented by Product Type (Retina & Glaucoma Examination Products [OCT Scanners, Perimeters, Fundus Cameras, Retinoscopes, Ophthalmoscopes, Ophthalmic Lasers & Ophthalmic Microscopes], Keratometers, Autorefractors, and Lensometers, Ophthalmic Ultrasound Systems & Digital Phoropters, Slit Lamps, Tonometers, Retinal Imaging Systems, General Examination Products, Chart Projectors, [Cataract & Cornea Examination Products, Specular Microscopes, Corneal Topography Systems, Wavefront Analyzers & Aberrometers, Optical Biometry Systems], Application (Cataract, Age-related Macular Degeneration, Glaucoma, Retinopathy, General Examination, Other Applications), End User (Hospitals, Clinics, Other End Users), and Geography. The study also evaluates industry competitors and analyzes their market shares at the country and regional levels.
Browse in depth @ https://www.meticulousresearch.com/product/optometry-equipment-market-5406?utm_source=article&utm_medium=social+&utm_campaign=product&utm_content=18-04-2024
Based on product type, in 2022, the retina & glaucoma examination products segment is expected to account for the largest share of the market. The large market share of this segment is attributed high penetration of retina examination products due to the high awareness of high-quality eye care and early and accurate diagnosis of common eye diseases such as macular degeneration, glaucoma, and diabetic retinopathy. The prevalence of diabetic retinopathy is rising globally, driving the demand for retina & glaucoma examination products.
Based on application, the optometry equipment market is segmented into cataract, age-related macular degeneration, glaucoma, retinopathy, general examination, and other applications. The general examination segment is projected to register the fastest growth rate over the forecast period. The growth of this segment is attributed to the growing geriatric population worldwide and the rising incidences of eye diseases primarily due to dependency on digital devices such as laptops, mobile phones, and others. General eye examinations help detect eye problems early when they can be treated most effectively. The awareness and importance of general eye examinations are high among all age groups, which is driving the growth of this market.
Key Players
The key players operating in the global optometry equipment market are NIDEK CO. LTD. (Japan), Carl Zeiss Meditec AG (Germany), Alcon (U.S.), Heidelberg Engineering GmbH (Germany), Johnson & Johnson (U.S.), Canon, Inc. (Japan), Bausch Health Companies Inc. (Canada), Escalon Medical Corp (U.S.), Topcon Healthcare Solutions, Inc. (U.S.), and HEINE Optotechnik GmbH & Co. KG (Germany).
Quick Buy: https://www.meticulousresearch.com/Checkout/36446863?utm_source=article&utm_medium=social+&utm_campaign=product&utm_content=18-04-2024
Contact Us: Meticulous Research® Email- [email protected] Contact Sales- +1-646-781-8004 Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
1 note · View note
spookysaladchaos · 5 months
Text
Pharmaceutical Grade Hyaluronic Acid Products, China Market Top 7 Companies Rank and Market Share
Pharmaceutical Grade Hyaluronic Acid Products Market Summary
Hyaluronic acid is a natural substance found in the fluids in the eyes and joints. It acts as a cushion and lubricant in the joints and other tissues.
According to the application, hyaluronic acid can be divided into pharmaceutical grade, cosmetic grade and food grade. Among them, pharmaceutical grade hyaluronic acid has the highest technical difficulty and quality requirements, so the price is also the most expensive.
Pharmaceutical grade hyaluronic acid products are products containing hyaluronic acid used in the pharmaceutical field, and can be divided into medical beauty, orthopedic treatment and ophthalmic treatment products.
Tumblr media
According to the new market research report “China Pharmaceutical Grade Hyaluronic Acid Products Market Report 2023-2029”, published by QYResearch, the China Pharmaceutical Grade Hyaluronic Acid Products market size is projected to reach USD 2,966 million by 2029, at a CAGR of 10.4% during the forecast period.
Figure.   China Pharmaceutical Grade Hyaluronic Acid Products Market Size (US$ Million), 2022 VS 2029
Tumblr media
Based on or includes research from QYResearch: China Pharmaceutical Grade Hyaluronic Acid Products Market Report 2023-2029.
Figure.   China Market Pharmaceutical Grade Hyaluronic Acid Products Top 7 Players Ranking and Market Share(Continually updated)
Tumblr media
Based on or includes research from QYResearch: China Pharmaceutical Grade Hyaluronic Acid Products Market Report 2023-2029. According to QYResearch Top Players Research Center, in China market, the key manufacturers of Pharmaceutical Grade Hyaluronic Acid Products include LG, Allergan, Humedix, Q-Med, Beijing Aimeike Biotech, Bloomage Biotechnology Corporation, Shanghai Haohai Biological Technology, etc. In 2022, the top five players had a share approximately 80.0% in terms of revenue.
  About The Authors Zhang Xuelu - Analyst for this report Email: [email protected]: www.qyresearch.com Hot Line:4006068865
QYResearch focus on Market Survey and Research US: +1-888-365-4458(US) +1-202-499-1434(Int'L) EU: +44-808-111-0143(UK) +44-203-734-8135(EU) Asia: +86-10-8294-5717(CN) +852-30628839(HK)
About QYResearch QYResearch founded in California, USA in 2007.It is a leading Global market research and consulting company. With over 16 years’ experience and professional research team in various cities over the world QY Research focuses on management consulting, database and seminar services, IPO consulting, industry chain research and customized research to help our clients in providing non-linear revenue model and make them successful. We are Globally recognized for our expansive portfolio of services, good corporate citizenship, and our strong commitment to sustainability. Up to now, we have cooperated with more than 60,000 clients across five continents. Let’s work closely with you and build a bold and better future. QYResearch is a world-renowned large-scale consulting company. The industry covers various high-tech industry chain market segments, spanning the semiconductor industry chain (semiconductor equipment and parts, semiconductor materials, ICs, Foundry, packaging and testing, discrete devices, sensors, optoelectronic devices), photovoltaic industry chain (equipment, cells, modules, auxiliary material brackets, inverters, power station terminals), new energy automobile industry chain (batteries and materials, auto parts, batteries, motors, electronic control, automotive semiconductors, etc.), communication industry chain (communication system equipment, terminal equipment, electronic components, RF front-end, optical modules, 4G/5G/6G, broadband, IoT, digital economy, AI), advanced materials industry Chain (metal materials, polymer materials, ceramic materials, nano materials, etc.), machinery manufacturing industry chain (CNC machine tools, construction machinery, electrical machinery, 3C automation, industrial robots, lasers, industrial control, drones), food, beverages and pharmaceuticals, medical equipment, agriculture, etc.
0 notes
marketblogresearch · 7 months
Text
Surgical Sutures Market Growth Drivers, Sales, Profits & Analysis by Forecast to 2030
The Insight Partners is excited to announce the release of groundbreaking findings in its latest market research report, "Overview of Surgical Sutures Market Share, Size, and Forecast | 2030". The panoramic research, conducted by our team of seasoned experts, provides valuable insights on the Surgical Sutures market forecast, key trends, drivers, challenges, and opportunities within the Surgical Sutures market.
The report unveils a detailed Surgical Sutures market analysis of the current Surgical Sutures market size and projects future growth trends based on historical data and market dynamics. At our research firm, we aim to help investors by providing both qualitative and quantitative data through this study. This global Surgical Sutures market report, competitive landscape, risks and barriers to entry for market players, sales channels, distributors, and Porter's Five Forces Analysis.
Businesses must have a firm understanding of the market, before making significant investments. It makes financial sense to allocate a modest portion of your company's expenditure to reliable market research. With a team of well-versed experts, we deliver actionable insights and strategic intelligence to help businesses navigate the complexities of the market landscape. Our commitment to excellence and innovation sets us apart as a trusted partner for organizations seeking a competitive edge.
Why Opt for Our Surgical Sutures Market Research Report?
Our researchers employ a multi-faceted approach to data collection, utilizing primary and secondary sources to ensure the breadth and depth of information.
Our researchers analyze consumer behavior, market trends, and brand positioning methods. Every piece of data undergoes a rigorous validation process to ensure accuracy and reliability.
We prioritize clarity and conciseness in our reporting, presenting findings in a format that is easily digestible for our clients.
We develop customized analytical models tailored to the specific nuances of the Surgical Sutures market, allowing us to uncover hidden patterns and trends.
The report answers the following questions:
What are the primary factors driving the Surgical Sutures market growth during the projected period?
What region is likely to witness the most substantial growth?
Which Surgical Sutures market trend will take center stage in the coming years?
What are the key challenges hindering the Surgical Sutures market expansion?
Emerging Trends: Our report uncovers emerging trends that are poised to reshape the Surgical Sutures market equipping businesses with the foresight to stay ahead of the competition.
Competitive Landscape: The Insight Partners explores the competitive landscape, offering insights into key Surgical Sutures market players, their strategies, and potential areas for differentiation. The key companies in the Surgical Sutures market are B. BRAUN MELSUNGEN AG , MEDTRONIC , ETHICON USA , LLC SMITH & NEPHEWATRAMAT , DEMETECH CORPORATION , SUTURES INDIA , P?TERS SURGICAL , TELEFLEX MEDICAL OEM , SERAG-WIESSNER GMBH & CO. KG .
Consumer Insights: Understanding consumer behavior is pivotal. The report includes a comprehensive analysis of consumer trends, preferences, and purchasing patterns.
Market Segmentation- The report breaks down the Surgical Sutures market into key segments, providing a detailed examination of each segment's market size, Surgical Sutures market growth potential, and strategic considerations.On the Basis of By Product this market is categorized further into-
Absorbable and Non-Absorbable
On the Basis of Application this market is categorized further into-
Cardiovascular Surgeries
Gynecological Surgeries
Ophthalmic Surgeries
Orthopedic Surgeries
On the Basis of Geography this market is categorized further into-
North America
Europe
Asia Pacific
and South and Central America
Key regions Surgical Sutures Market Research Report:
North America (U.S., Canada, Mexico)
Europe (U.K., France, Germany, Spain, Italy, Central & Eastern Europe, CIS)
Asia Pacific (China, Japan, South Korea, ASEAN, India, Rest of Asia Pacific)
Latin America (Brazil, Rest of Latin America)
The Middle East and Africa (Turkey, GCC, Rest of the Middle East and Africa)
Rest of the World
Published By :-
Avi
Senior Market Research expert at The Insight Partners
0 notes
rjshitalbakch · 7 months
Text
0 notes
priyablog26 · 8 months
Text
Healthcare Equipment Market May See a Big Move 2024-2030
 Healthcare Equipment  Market May See a Big Move 2024-2030
Global Healthcare Equipment   Market, Healthcare Equipment  Market Demand, Healthcare Equipment  Market Trends, Healthcare Equipment  Market Analysis, Healthcare Equipment  Market Growth, Healthcare Equipment  Market Share, Healthcare Equipment  Market Forecast, Healthcare Equipment  Market Challenges, Healthcare Equipment  Market Opportunity
At Intellect Markets, published a new research publication on "Healthcare Equipment  Market Insights, to 2030" with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting Market associated stakeholders. The growth of the Healthcare Equipment  Market was mainly driven by the increasing R&D spending across the world.
Get Free Exclusive PDF Sample Copy of This Research @  https://intellectmarkets.com/report/healthcare-equipment-market/request-sample
Some of the key players profiled in the study are:
Diagnostic Imaging Equipment, Electrosurgical Equipment, Orthopedic Devices, Cardiovascular Devices, Diagnostic Imaging, IVD, MIS, Diabetes Care, Ophthalmic, Dental, Nephrology, General Surgery, Endoscopic Devices, Laboratory Equipment, Others.
Scope of the Report of Healthcare Equipment  Market: Healthcare Equipment Market employs a robust research methodology, encompassing past, present, and future analyses. Analyse the drivers, restraints, opportunities, and challenges influencing the Healthcare Equipment market. The Global Healthcare Equipment Market report serves as a valuable resource for understanding the market dynamics and making strategic decisions in this evolving industry. The Global Healthcare Equipment Market report plays a crucial role in providing a comprehensive overview of the market dynamics. It evaluates key segments, identifies emerging trends, assesses drivers and restraints, and offers insights into the competitive landscape.
Market Trends: As the prevalence of chronic illnesses continues to escalate, healthcare organizations are increasingly prioritizing early detection and treatment. Concurrently, a growing number of patients undergo diagnostic and surgical procedures, propelling the expansion of the healthcare equipment market.
Opportunities: An integral facet of patient therapy in hospitals revolves around the utilization of equipment. The equipment deployed in hospitals significantly influences various activities and plays a pivotal role in determining the effectiveness of treatments. Additionally, it has a profound impact on patients' perceptions and the overall therapeutic experience. Healthcare equipment serves diverse purposes, including diagnosis, monitoring, and treatment. Advancements in medical technology facilitate accurate diagnosis across various medical indications, thereby enhancing treatment precision. The escalating prevalence of conditions such as arthritis, liver inflammation, cancer, renal diseases, diabetes, chronic pain, sciatica, and other nerve disorders is driving the heightened demand for healthcare equipment.
Market Drivers: The market is witnessing expansion due to the escalating trend of increased healthcare spending and the dynamically evolving healthcare landscape
There is a growing demand for portable devices as the focus shifts toward homecare settings.
Have Any Questions Regarding Global Healthcare Equipment  Market Report, Ask Our Experts@ https://intellectmarkets.com/report/healthcare-equipment-market/ask-an-expert
The Titled Segments and Sub-Section of The Market Are Illuminated Below: Healthcare Equipment Market Research Report – Segmented By Device Type (Diagnostic Imaging Equipment, Electrosurgical Equipment, Orthopedic Devices, Cardiovascular Devices, Diagnostic Imaging, IVD, MIS, Diabetes Care, Ophthalmic, Dental, Nephrology, General Surgery, Endoscopic Devices, Laboratory Equipment, Others); End-User (Hospital, Diagnostic Imaging Centers, Dialysis Centers, Ambulatory Surgical Centers, Dental Clinics & Speciality Clinics, Other ).
Region Included are: Global, North America, Europe, Asia Pacific, South America, Middle East & Africa
Country Level Break-Up: United States, Canada, Mexico, Brazil, Argentina, Colombia, Chile, South Africa, Nigeria, Tunisia, Morocco, Germany, United Kingdom (UK), the Netherlands, Spain, Italy, Belgium, Austria, Türkiye, Russia, France, Poland, Israel, United Arab Emirates, Qatar, Saudi Arabia, China, Japan, Taiwan, South Korea, Singapore, India, Australia and New Zealand etc.
Read Detailed Index of Full Research Study at https://intellectmarkets.com/report/healthcare-equipment-market
Thanks for reading this article; you can also get region wise report version like Global, North America, Middle East, Africa, Europe, South America, etc
Contact US: Intellect Markets, Unit No. 4, Lakshmi Enclave, Nizam pet, Hyderabad, Telangana, India - 500090 Phone: +1 347 514 7411, +91 8688234923 [email protected]
0 notes
Text
Lateral Flow Assay Market worth $16.8 billion by 2029
Lateral Flow Assays Market in terms of revenue was estimated to be worth $10.8 billion in 2023 and is poised to reach $16.8 billion by 2029, growing at a CAGR of 7.6% from 2023 to 2029 according to a new report by MarketsandMarkets™. The rising demand of lateral flow assays due to increasing number of geriatric populations, growing prevalence of infectious diseases as well as increasing of point of care tests are some of the key factors that are driving the growth of this market. However, the hesitance in the patients as well as in health professionals to change in the conventional diagnostic method and the lack of accuracy of lateral flow assays are some of the key restraints for lateral flow assays market.
Lateral Flow Assays Market Size, Dynamics & Ecosystem
Tumblr media
Download an Illustrative overview:
Browse in-depth TOC on "Lateral Flow Assays Market"
420 - Tables
59 - Figures
399 – Pages
"Kits and Reagents segment is expected to witness the highest growth during the forecast period"
Based on product type, the lateral flow assays market is segmented into kits & reagents and lateral flow readers. During the forecast period, the the lateral flow readers segment is expected to witness the second highest growth during the forecast period. The growth of this segment can be attributed as these are economical, quantitative as well as capability of assaying multiple analytes simultaneously.
"Veterinary Diagnostic segment accounted for the second largest share of lateral flow assays market in 2022"
Based on applications, the lateral flow assays market is segmented into clinical testing, veterinary diagnostics, food safety & environmental testing, and drug development & quality testing. The veterinary diagnostic segment accounted for the second largest share of the lateral flow assays market in 2022.In the veterinary diagnostic segment, lateral flow tests are used to test commercial livestock and household pets for various medical conditions, including bacterial and viral infections, allergies, fertility issues, and diabetes. The possibility of infectious disease outbreaks (particularly in large livestock animals) drives the demand for lateral flow tests due to their simplicity and rapidity compared to conventional detection methods.
"The multiplex detection assays technique is expected to witness the fastest growth during the forecast period"
Based on technique, the lateral flow assay kits & reagents market is segmented into competitive assays, sandwich assays, and multiplex detection assays. The multiplex detection assays technique anticipated to undergo the most substantial growth in the given forecast period. The multiplex assays are useful in clinical diagnosis as it allows to help and decide the stage of a disease where multiple interdependent analytes are involved in the test process. It is highly desirable to analyze multiple analytes simultaneously under the same set of conditions.
North America is expected to account for the largest share of the lateral flow assays industry.
North America has some of the highest worldwide healthcare spending rates, which translates into large investments in state-of-the-art ophthalmic technology. This encourages the creation and uptake of cutting-edge technology, expanding the realm of what is practical for preventive and vision restoration. World-class research facilities and medical centers that are at the forefront of ocular research and development can be found in the area. This creates a vibrant ecosystem that encourages innovation, which results in a steady supply of new and enhanced equipment coming to market. Naturally, as North America's population ages, age-related eye conditions like cataracts and macular degeneration become more common. Growth is further accelerated as a result of the expanded market for diagnostic and therapeutic equipment.
Request Sample Pages:
Lateral Flow Assays Market Dynamics:
Drivers:
High prevalence of infectious diseases
Rising geriatric population
Growing use of home-based lateral flow assay devices
Growing demand for POC testing
Restraints:
Inconsistent results of lateral flow assay tests
Opportunities:
Evolving applications of lateral flow assays
Rising demand for lateral flow assays in food & beverage industry
Emergence of Omicron COVID variant
Challenge:
Limited reimbursements for lateral flow assay products
Difficulties in procuring quality raw materials to develop tests
Key Market Players of Lateral Flow Assays Industry:
The key players in the global lateral flow assays market include Abbott Laboratories (US), Quidel Corporation (US), F. Hoffman-La Roche AG (Switzerland), Danaher Corporation (US), Siemens AG (Germany), BD (US), bioMérieux SA (France), Thermo Fisher Scientific, Inc. (US), and PerkinElmer Inc. (US).
A breakdown of the primary participants (supply-side) for the lateral flow assays market referred to for this report is provided below:
By Company Type: Tier 1–35%, Tier 2–20%, and Tier 3–45%
By Designation: C-level–45%, Director Level–25%, and Others–30%
By Region: North America–36%, Europe–26%, Asia Pacific–21%, Latin America- 10%, and Middle East and Africa– 7%
Recent Developments of Lateral Flow Assays Industry:
In August 2023, Quidelortho received authorization from the US Food and Drug Administration (FDA), allowing the company to market its new Sofia 2 SARS Antigen+ FIA.
In February 2022, Abbott Laboratories received FDA Emergency Use Authorization (EUA) for its Alinity M assay to detect antibodies to SARS-CoV-2.
In October 2022, Roche launched the next-generation portfolio of SARS-CoV-2 rapid antigen tests ("2.0").
Get 10% Free Customization on this Report:
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Research Insights: https://www.marketsandmarkets.com/ResearchInsight/lateral-flow-assay-market.asp
Visit Our Website: https://www.marketsandmarkets.com/
Content Source: https://www.marketsandmarkets.com/PressReleases/lateral-flow-assay.asp
Related Reports:
0 notes
fadingtrashkitty · 4 months
Text
0 notes